
Long-term health-related quality of life in head and neck cancer survivors : a large multinational study
- Author
- Katherine J. Taylor, Cecilie D. Amdal, Kristin Bjordal, Guro L. Astrup, Bente B. Herlofson, Fréderic Duprez (UGent) , Ricardo R. Gama, Alexandre Jacinto, Eva Hammerlid, Melissa Scricciolo, Femke Jansen, Irma M. Verdonck-de Leeuw, Giuseppe Fanetti, Orlando Guntinas-Lichius, Johanna Inhestern, Tatiana Dragan, Alexander Fabian, Andreas Boehm, Ulrike Woehner, Naomi Kiyota, Maximilian Krueger, Pierluigi Bonomo, Monica Pinto, Sandra Nuyts, Joaquim Castro Silva, Carmen Stromberger, Pol Specenier, Francesco Tramacere, Ayman Bushnak, Pietro Perotti, Michaela Plath, Alberto Paderno, Noa Stempler, Maria Kouri, Vincent Gregoire, Susanne Singer, EORTC Quality Life Grp and EORTC Head Neck Grp
- Organization
- Abstract
- Head and neck cancer (HNC) patients suffer from a range of health-related quality of life (HRQoL) issues, but little is known about their long-term HRQoL. This study explored associations between treatment group and HRQoL at least 5 years' post-diagnosis in HNC survivors. In an international cross-sectional study, HNC survivors completed the European Organization for Research and Treatment of Cancer (EORTC) quality of life core questionnaire (EORTC-QLQ-C30) and its HNC module (EORTC-QLQ-H&N35). Meaningful HRQoL differences were examined between five treatment groups: (a) surgery, (b) radiotherapy, (c) chemo-radiotherapy, (d) radiotherapy +/- chemotherapy and neck dissection and (e) any other surgery (meaning any tumour surgery that is not a neck dissection) and radiotherapy +/- chemotherapy. Twenty-six sites in 11 countries enrolled 1105 survivors. They had a median time since diagnosis of 8 years, a mean age of 66 years and 71% were male. After adjusting for age, sex, tumour site and UICC stage, there was evidence for meaningful differences (10 points or more) in HRQoL between treatment groups in seven domains (Fatigue, Mouth Pain, Swallowing, Senses, Opening Mouth, Dry Mouth and Sticky Saliva). Survivors who had single-modality treatment had better or equal HRQoL in every domain compared to survivors with multimodal treatment, with the largest differences for Dry Mouth and Sticky Saliva. For Global Quality of Life, Physical and Social Functioning, Constipation, Dyspnoea and Financial Difficulties, at least some treatment groups had better outcomes compared to a general population. Our data suggest that multimodal treatment is associated with worse HRQoL in the long-term compared to single modality.
- Keywords
- treatment, survivor, quality of life, head and neck cancer, cross-sectional
Downloads
-
published version.pdf
- full text (Published version)
- |
- open access
- |
- |
- 1.01 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HR7F908JT9CC3BAD7CNSDZBW
- MLA
- Taylor, Katherine J., et al. “Long-Term Health-Related Quality of Life in Head and Neck Cancer Survivors : A Large Multinational Study.” INTERNATIONAL JOURNAL OF CANCER, vol. 154, no. 10, 2024, pp. 1772–85, doi:10.1002/ijc.34861.
- APA
- Taylor, K. J., Amdal, C. D., Bjordal, K., Astrup, G. L., Herlofson, B. B., Duprez, F., … Head Neck Grp, E. (2024). Long-term health-related quality of life in head and neck cancer survivors : a large multinational study. INTERNATIONAL JOURNAL OF CANCER, 154(10), 1772–1785. https://doi.org/10.1002/ijc.34861
- Chicago author-date
- Taylor, Katherine J., Cecilie D. Amdal, Kristin Bjordal, Guro L. Astrup, Bente B. Herlofson, Fréderic Duprez, Ricardo R. Gama, et al. 2024. “Long-Term Health-Related Quality of Life in Head and Neck Cancer Survivors : A Large Multinational Study.” INTERNATIONAL JOURNAL OF CANCER 154 (10): 1772–85. https://doi.org/10.1002/ijc.34861.
- Chicago author-date (all authors)
- Taylor, Katherine J., Cecilie D. Amdal, Kristin Bjordal, Guro L. Astrup, Bente B. Herlofson, Fréderic Duprez, Ricardo R. Gama, Alexandre Jacinto, Eva Hammerlid, Melissa Scricciolo, Femke Jansen, Irma M. Verdonck-de Leeuw, Giuseppe Fanetti, Orlando Guntinas-Lichius, Johanna Inhestern, Tatiana Dragan, Alexander Fabian, Andreas Boehm, Ulrike Woehner, Naomi Kiyota, Maximilian Krueger, Pierluigi Bonomo, Monica Pinto, Sandra Nuyts, Joaquim Castro Silva, Carmen Stromberger, Pol Specenier, Francesco Tramacere, Ayman Bushnak, Pietro Perotti, Michaela Plath, Alberto Paderno, Noa Stempler, Maria Kouri, Vincent Gregoire, Susanne Singer, EORTC Quality Life Grp, and EORTC Head Neck Grp. 2024. “Long-Term Health-Related Quality of Life in Head and Neck Cancer Survivors : A Large Multinational Study.” INTERNATIONAL JOURNAL OF CANCER 154 (10): 1772–1785. doi:10.1002/ijc.34861.
- Vancouver
- 1.Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, et al. Long-term health-related quality of life in head and neck cancer survivors : a large multinational study. INTERNATIONAL JOURNAL OF CANCER. 2024;154(10):1772–85.
- IEEE
- [1]K. J. Taylor et al., “Long-term health-related quality of life in head and neck cancer survivors : a large multinational study,” INTERNATIONAL JOURNAL OF CANCER, vol. 154, no. 10, pp. 1772–1785, 2024.
@article{01HR7F908JT9CC3BAD7CNSDZBW, abstract = {{Head and neck cancer (HNC) patients suffer from a range of health-related quality of life (HRQoL) issues, but little is known about their long-term HRQoL. This study explored associations between treatment group and HRQoL at least 5 years' post-diagnosis in HNC survivors. In an international cross-sectional study, HNC survivors completed the European Organization for Research and Treatment of Cancer (EORTC) quality of life core questionnaire (EORTC-QLQ-C30) and its HNC module (EORTC-QLQ-H&N35). Meaningful HRQoL differences were examined between five treatment groups: (a) surgery, (b) radiotherapy, (c) chemo-radiotherapy, (d) radiotherapy +/- chemotherapy and neck dissection and (e) any other surgery (meaning any tumour surgery that is not a neck dissection) and radiotherapy +/- chemotherapy. Twenty-six sites in 11 countries enrolled 1105 survivors. They had a median time since diagnosis of 8 years, a mean age of 66 years and 71% were male. After adjusting for age, sex, tumour site and UICC stage, there was evidence for meaningful differences (10 points or more) in HRQoL between treatment groups in seven domains (Fatigue, Mouth Pain, Swallowing, Senses, Opening Mouth, Dry Mouth and Sticky Saliva). Survivors who had single-modality treatment had better or equal HRQoL in every domain compared to survivors with multimodal treatment, with the largest differences for Dry Mouth and Sticky Saliva. For Global Quality of Life, Physical and Social Functioning, Constipation, Dyspnoea and Financial Difficulties, at least some treatment groups had better outcomes compared to a general population. Our data suggest that multimodal treatment is associated with worse HRQoL in the long-term compared to single modality.}}, author = {{Taylor, Katherine J. and Amdal, Cecilie D. and Bjordal, Kristin and Astrup, Guro L. and Herlofson, Bente B. and Duprez, Fréderic and Gama, Ricardo R. and Jacinto, Alexandre and Hammerlid, Eva and Scricciolo, Melissa and Jansen, Femke and Verdonck-de Leeuw, Irma M. and Fanetti, Giuseppe and Guntinas-Lichius, Orlando and Inhestern, Johanna and Dragan, Tatiana and Fabian, Alexander and Boehm, Andreas and Woehner, Ulrike and Kiyota, Naomi and Krueger, Maximilian and Bonomo, Pierluigi and Pinto, Monica and Nuyts, Sandra and Silva, Joaquim Castro and Stromberger, Carmen and Specenier, Pol and Tramacere, Francesco and Bushnak, Ayman and Perotti, Pietro and Plath, Michaela and Paderno, Alberto and Stempler, Noa and Kouri, Maria and Gregoire, Vincent and Singer, Susanne and Quality Life Grp, EORTC and Head Neck Grp, EORTC}}, issn = {{0020-7136}}, journal = {{INTERNATIONAL JOURNAL OF CANCER}}, keywords = {{treatment,survivor,quality of life,head and neck cancer,cross-sectional}}, language = {{eng}}, number = {{10}}, pages = {{1772--1785}}, title = {{Long-term health-related quality of life in head and neck cancer survivors : a large multinational study}}, url = {{http://doi.org/10.1002/ijc.34861}}, volume = {{154}}, year = {{2024}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: